“…Canonical Wnt ligands (Wnt-1, 2, 3, 8a, 8b, 10a, and 10b) were reported to be expressed in 100% of ameloblastomas (n=72) representing unicystic, solid/multicystic, and desmoplastic subtypes, and including 10 cases of recurrent ameloblastoma (Siar 2012). The expression of β-catenin, the signal transducer of canonical Wnt signaling, is inconsistently reported, with expression detected by immunohistochemistry in 15–100% of ameloblastomas [62–69]. Overall, 82% of ameloblastomas express β-catenin (n=137).…”